Willemse, P H <br/><br/>
A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  1992 
 - 479-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/s0959-8049(05)80081-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Drug Evaluation<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Infusions, Parenteral<br/>Injections, Intravenous<br/>Leukopenia--chemically induced<br/>Middle Aged<br/>Ovarian Neoplasms--drug therapy